Scholars Central

ArticlePublished 18 Dec 2023

Comparative study of intravenous thrombolysis for acute ischemic stroke in mongolian patients aged above and below 50 years

Authors: Delgermaa Tsagaankhuu, Chimeglkham Banzrai, Tsagaankhuu Guntev, Baigalmaa Gongor

Systematic Reviews in Pharmacy

Volume 14 · Issue 12 · Pages 757–761

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objective: The present study aimed to compare the safety and efficacy of Intravenous Thrombolysis (IVT) between Mongolian young and older patients with Acute Ischemic Stroke (AIS). Methods: Data of 115 AIS patients who received recombinant tissue Plasminogen Activator (rt-PA) between May 2013 and May 2023 at the Stroke Center of Third Central Hospital were retrospectively analyzed. Patients aged <50 years (n=31) compared with those aged ≥ 50 years (n=84) with regards to baseline characteristics, symptomatic Intracerebral Haemorrhage (sICH), functional outcomes at 3 months defined as “favorable” and “poor” (modified Rankin Scale score 0-2 vs. 3-6) including in-hospital mortality. Results: 27% of patients were <50 years old (54.8% males; mean age 42.7 ± 5.8 years). Ischemic heart disease was significantly less common in younger patients than older (22.6% vs. 58.3%, p=0.018) and the prevalence of other determined ethiology was higher (p<0.05) in patients aged <50 years. “Favorable” outcome at 3 months was significantly higher in young adults (61.3% vs.36.9%, p=0.033) and sICH was found in 3.3% of the patients aged <50 years (p=0.897) compared to 6.0% in the older than 50 years. Mortality was present in 9.7% of the patients aged <50 years and in 21.4% of the patients aged ≥ 50 years (p=0.182). Conclusion: We conclude that Mongolian young stroke patients treated with IVT had a more favorable outcome without an increased risk of sICH and mortality compared with older patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Systematic Reviews in Pharmacy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalSystematic Reviews in Pharmacy
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Delgermaa Tsagaankhuu”
  • BylineArticles whose byline prints “Chimeglkham Banzrai”
  • BylineArticles whose byline prints “Tsagaankhuu Guntev”
  • BylineArticles whose byline prints “Baigalmaa Gongor”